Arq Reports Second Quarter 2026 Results
Bullish on ARQ near-term on solid profitability trend and PFAS PAC upside; catalysts in 6–12 months.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Bullish on ARQ near-term on solid profitability trend and PFAS PAC upside; catalysts in 6–12 months.
What happened and why it matters
Arq posted $29.9 million in Q2 2026 revenue and 38.5% gross margin, with Adjusted EBITDA of $5.8 million, marking the ninth straight positive quarter. The company reaffirmed 2026 guidance and highlighted PFAS-focused PAC initiatives and ongoing GAC optimization as potential catalysts for 2027 growth, while noting a leaner immediate cash position and moderate debt.
The beat on profitability metrics, margin expansion, and reaffirmed full-year guidance typically drives short-term upside for a small-cap. PFAS PAC potential could compound mid-term value, though liquidity and leverage caveats exist. Historical precedent: earnings-driven re-ratings at mid-caps when guidance is reaffirmed and new product avenues are highlighted.
Q2 2026 revenue $29.9M, up 5% YoY. Gross margin 38.5% (+520 bps).
Adjusted EBITDA $5.8M; 9th consecutive quarter of positive EBITDA.
Reaffirms 2026 guidance: $120-125M revenue, $17-20M Adjusted EBITDA.
PFAS PAC initiative progress could lift volumes/margins in 2027.
Red River plant turnaround completed under budget; 2026 capex guidance $8-10M.
Category: Earnings. The release combines quarterly results with strategic updates (PFAS PAC, GAC optimization) that can influence ARQ's margin trajectory and long-term growth optionality.
More AI-analyzed coverage connected to this story